|
Acelerar Diagnostics, Inc. (AXDX) Valoración de DCF
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Accelerate Diagnostics, Inc. (AXDX) Bundle
¡Ahorre tiempo y mejore la precisión con nuestra calculadora DCF (AXDX)! Con datos reales de Accelerate Diagnostics, Inc. y suposiciones personalizables, esta herramienta le permite pronosticar, analizar y valor (AXDX) como un inversor experimentado.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.3 | 11.2 | 11.8 | 12.8 | 12.1 | 12.9 | 13.8 | 14.8 | 15.9 | 17.0 |
| Revenue Growth, % | 0 | 20.09 | 5.53 | 8.23 | -5.43 | 7.1 | 7.1 | 7.1 | 7.1 | 7.1 |
| EBITDA | -67.6 | -59.7 | -59.6 | -55.8 | -49.8 | -12.9 | -13.8 | -14.8 | -15.9 | -17.0 |
| EBITDA, % | -726.66 | -534.31 | -505.81 | -437.57 | -412.73 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 2.6 | 3.0 | 2.5 | 3.0 | 3.3 | 3.3 | 3.5 | 3.8 | 4.0 | 4.3 |
| Depreciation, % | 27.99 | 26.84 | 21.37 | 23.53 | 26.98 | 25.34 | 25.34 | 25.34 | 25.34 | 25.34 |
| EBIT | -70.2 | -62.7 | -62.1 | -58.8 | -53.0 | -12.9 | -13.8 | -14.8 | -15.9 | -17.0 |
| EBIT, % | -754.65 | -561.16 | -527.18 | -461.1 | -439.71 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 108.5 | 68.3 | 63.6 | 45.6 | 13.2 | 12.9 | 13.8 | 14.8 | 15.9 | 17.0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 3.2 | 1.6 | 2.3 | 2.4 | 2.6 | 2.8 | 3.0 | 3.2 | 3.5 | 3.7 |
| Account Receivables, % | 34.66 | 13.88 | 19.69 | 18.95 | 21.74 | 21.78 | 21.78 | 21.78 | 21.78 | 21.78 |
| Inventories | 8.1 | 9.2 | 5.1 | 5.2 | 3.3 | 7.2 | 7.8 | 8.3 | 8.9 | 9.5 |
| Inventories, % | 86.68 | 82.54 | 43.01 | 40.73 | 27.45 | 56.08 | 56.08 | 56.08 | 56.08 | 56.08 |
| Accounts Payable | 2.4 | 1.3 | 2.0 | 4.5 | 4.8 | 3.3 | 3.6 | 3.8 | 4.1 | 4.4 |
| Accounts Payable, % | 25.29 | 11.55 | 16.83 | 35.3 | 39.77 | 25.75 | 25.75 | 25.75 | 25.75 | 25.75 |
| Capital Expenditure | -.3 | -1.4 | -.6 | -.6 | -1.0 | -.9 | -.9 | -1.0 | -1.1 | -1.1 |
| Capital Expenditure, % | -3.55 | -12.2 | -5.12 | -4.34 | -8.58 | -6.76 | -6.76 | -6.76 | -6.76 | -6.76 |
| Tax Rate, % | -1.4 | -1.4 | -1.4 | -1.4 | -1.4 | -1.4 | -1.4 | -1.4 | -1.4 | -1.4 |
| EBITAT | -70.1 | -62.7 | -62.1 | -58.7 | -53.8 | -12.9 | -13.8 | -14.8 | -15.9 | -17.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -76.7 | -61.6 | -56.2 | -54.0 | -49.6 | -16.1 | -11.7 | -12.6 | -13.5 | -14.4 |
| WACC, % | 16.49 | 16.51 | 16.51 | 16.49 | 16.51 | 16.5 | 16.5 | 16.5 | 16.5 | 16.5 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -44.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -15 | |||||||||
| Terminal Value | -101 | |||||||||
| Present Terminal Value | -47 | |||||||||
| Enterprise Value | -92 | |||||||||
| Net Debt | 27 | |||||||||
| Equity Value | -119 | |||||||||
| Diluted Shares Outstanding, MM | 12 | |||||||||
| Equity Value Per Share | -9.52 |
What You Will Get
- Accurate AXDX Financial Data: Pre-filled with Accelerate Diagnostics’ historical and projected data for detailed analysis.
- Fully Customizable Template: Easily adjust key inputs such as revenue growth, WACC, and EBITDA %.
- Instant Calculations: Watch as Accelerate Diagnostics’ intrinsic value updates in real-time based on your modifications.
- Professional Valuation Tool: Tailored for investors, analysts, and consultants aiming for precise DCF outcomes.
- User-Friendly Interface: Straightforward layout and clear guidance suitable for all skill levels.
Key Features
- Comprehensive Financial Data: Gain access to precise pre-loaded historical figures and future forecasts for Accelerate Diagnostics, Inc. (AXDX).
- Adjustable Forecast Parameters: Modify highlighted cells for key assumptions such as WACC, growth rates, and profit margins.
- Real-Time Calculations: Enjoy automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
- User-Friendly Dashboard: Intuitive charts and summaries to help you visualize your valuation outcomes.
- Designed for All Skill Levels: An easy-to-navigate layout tailored for investors, CFOs, and consultants alike.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Accelerate Diagnostics data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Accelerate Diagnostics’ intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for Accelerate Diagnostics, Inc. (AXDX)?
- Accurate Data: Real Accelerate Diagnostics financials ensure reliable valuation results.
- Customizable: Adjust key parameters like growth rates, WACC, and tax rates to align with your projections.
- Time-Saving: Pre-built calculations streamline your workflow and eliminate the need to start from scratch.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the healthcare sector.
- User-Friendly: Intuitive design and step-by-step guidance make it accessible for all users.
Who Should Use This Product?
- Healthcare Professionals: Assess the financial health of Accelerate Diagnostics, Inc. (AXDX) for informed decision-making.
- Investors: Develop comprehensive valuation models to evaluate investment opportunities in AXDX.
- Market Analysts: Analyze market trends and performance metrics related to Accelerate Diagnostics, Inc. (AXDX).
- Students and Educators: Utilize real-time data to enhance learning and teaching in financial analysis.
- Biotech Enthusiasts: Gain insights into how companies like Accelerate Diagnostics, Inc. (AXDX) are valued within the biotechnology sector.
What the Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations specific to Accelerate Diagnostics, Inc. (AXDX).
- Real-World Data: Historical and projected financials for Accelerate Diagnostics, Inc. (AXDX) preloaded for in-depth analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to evaluate different scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into the company’s performance.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to Accelerate Diagnostics, Inc. (AXDX).
- Dashboard with Visual Outputs: Visualizations including charts and tables for clear, actionable insights.